OverviewSuggest Edit

Lantern Pharma is a biotechnology company developing precision cancer drugs. It offers therapies using genomic data, machine learning, and computational biology modeling to identify the patient groups most likely to respond to therapy and to clarify the potential underlying mechanism(s) of action.

TypePublic
Founded2013
HQDallas, TX, US
Websitelanternpharma.com
Overall CultureB-

Latest Updates

Employees (est.) (Jun 2020)12(+200%)
Share Price (Nov 2021)$9.8
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Lantern Pharma

Panna Sharma

Panna Sharma

Chief Executive Officer, President and Director
David R. Margrave

David R. Margrave

Chief Financial Officer and Secretary
Peter Nara

Peter Nara

Co-Founder, Advisor
Kishor G. Bhatia

Kishor G. Bhatia

Chief Scientific Officer
David S. Silberstein

David S. Silberstein

Director
Jeff Keyser

Jeff Keyser

Chairman
Show more

Lantern Pharma Office Locations

Lantern Pharma has an office in Dallas
Dallas, TX, US (HQ)
1920 McKinney Ave 7th Floor
Show all (1)

Lantern Pharma Financials and Metrics

Lantern Pharma Revenue

USD

Net income (Q1, 2021)

(2.5m)

Market capitalization (12-Nov-2021)

108.4m

Closing stock price (12-Nov-2021)

9.8

Cash (31-Mar-2021)

81.4m
Lantern Pharma's current market capitalization is $108.4 m.
Annual
USDFY, 2018FY, 2019FY, 2020

General and administrative expense

1.2m1.5m3.7m

R&D expense

572.1k953.2k

Operating expense total

1.7m2.4m3.7m

Net Income

(1.7m)(2.4m)(5.9m)
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

General and administrative expense

267.9k268.1k441.3k340.2k676.4k1.1m1.2m

R&D expense

186.0k361.3k228.4k137.1k157.0k600.8k1.3m

Operating expense total

454.0k629.4k669.7k477.3k833.4k1.7m2.5m

Net Income

(454.0k)(629.4k)(669.7k)(477.3k)(833.4k)(1.7m)(2.5m)
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

445.2k1.2m19.2m

Prepaid Expenses

788.01.0m

Current Assets

445.2k1.2m20.2m

PP&E

4.7k8.8k21.5k
Quarterly
USDQ1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

634.2k23.8m20.8m81.4m

Prepaid Expenses

132.1k70.8k1.7m1.1m

Current Assets

766.4k25.6m22.5m82.5m

PP&E

8.2k15.4k17.6k20.2k
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

(1.7m)(2.4m)(5.9m)

Depreciation and Amortization

(2.5k)1.6k3.4k

Accounts Payable

70.2k372.7k(169.0k)

Cash From Operating Activities

(1.3m)(2.1m)(5.7m)
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

(454.0k)(1.1m)(1.8m)(477.3k)(1.3m)(3.0m)(2.5m)

Depreciation and Amortization

315.0629.01.1k536.01.2k2.3k1.3k

Accounts Payable

57.5k224.4k304.5k(41.0k)(61.7k)431.0k164.1k

Cash From Operating Activities

(425.6k)(869.1k)(1.4m)(703.0k)(1.2m)(4.1m)(2.1m)
USDFY, 2018

Financial Leverage

-2.2 x
Show all financial metrics

Lantern Pharma Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Lantern Pharma Online and Social Media Presence

Embed Graph

Lantern Pharma Company Culture

  • Overall Culture

    B-

    79/100

  • CEO Rating

    A+

    85/100

  • Compensation

    D-

    50/100

Learn more on Comparably

Lantern Pharma News and Updates

Lantern Pharma to Host Virtual KOL Event on the Potential Treatment of Pancreatic Cancer with Drug Candidate LP-184 on November 18th, World Pancreatic Cancer Day

DALLAS, Nov. 12, 2021 /PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced it...

Lantern Pharma Announces Abstract on Effectiveness of LP-284 in Hematologic Cancers Accepted for Presentation at the 63rd American Society of Hematology (ASH) Annual Meeting

DALLAS, Nov. 4, 2021 /PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that...

Code Ocean Selected by Lantern Pharma to Power A.I. Focused Computational Research Environment for Oncology Drug Development

NEW YORK and DALLAS, Oct. 27, 2021 /PRNewswire/ -- Code Ocean, the leading computational research environment for sharing scientific discoveries, today announced a collaboration that will power AI-driven computational research for oncology-focused drug discovery with Lantern Pharma...

Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th

DALLAS, Sept. 22, 2021 /PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that...

Lantern Pharma Expands Management Team with Appointment of Two Leading Industry Executives to Support Clinical and Manufacturing Initiatives

DALLAS, Sept. 2, 2021 /PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced the...
Show more

Lantern Pharma Frequently Asked Questions

  • When was Lantern Pharma founded?

    Lantern Pharma was founded in 2013.

  • Who are Lantern Pharma key executives?

    Lantern Pharma's key executives are Panna Sharma, David R. Margrave and Peter Nara.

  • How many employees does Lantern Pharma have?

    Lantern Pharma has 12 employees.

  • Who are Lantern Pharma competitors?

    Competitors of Lantern Pharma include NexImmune, centrose and BenevolentAI.

  • Where is Lantern Pharma headquarters?

    Lantern Pharma headquarters is located at 1920 McKinney Ave 7th Floor, Dallas.

  • Where are Lantern Pharma offices?

    Lantern Pharma has an office in Dallas.

  • How many offices does Lantern Pharma have?

    Lantern Pharma has 1 office.